Examiner: OUSPENSKI, ILIA I

Tech Center 3700 • Art Units: 1644 3792

This examiner grants 78% of resolved cases

Performance Statistics

77.5%

Allow Rate

+7.5% vs TC avg

1,160

Total Applications

+20.4%

Interview Lift

970

Avg Prosecution Days

Based on 1120 resolved cases, 2023–2026

3.8%

§101 Eligibility

20.4%

§102 Novelty

9.5%

§103 Obviousness

38.2%

§112 Clarity

App #	Title	Status	Assignee
17926254	COMPOSITIONS AND METHODS FOR PRODUCING HUMAN POLYCLONAL ANTIBODIES	Non-Final OA	FLAGSHIP PIONEERING INNOVATIONS VI, LLC
18279965	METHOD FOR PRODUCING CHIMERIC ANTIGEN RECEPTOR-MACROPHAGES AND USE OF SAME CELLS	Non-Final OA	KNU-INDUSTRY COOPERATION FOUNDATION

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.